- Home
- OBK vs SEPN Comparison
OBK vs SEPN Comparison
Compare OBK & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBK
- SEPN
- Stock Information
- Founded
- OBK 1912
- SEPN 2022
- Country
- OBK United States
- SEPN United States
- Employees
- OBK N/A
- SEPN N/A
- Industry
- OBK Major Banks
- SEPN
- Sector
- OBK Finance
- SEPN
- Exchange
- OBK Nasdaq
- SEPN NYSE
- Market Cap
- OBK 1.1B
- SEPN 1.0B
- IPO Year
- OBK 2018
- SEPN 2024
- Fundamental
- Price
- OBK $35.68
- SEPN $18.70
- Analyst Decision
- OBK Buy
- SEPN Strong Buy
- Analyst Count
- OBK 5
- SEPN 4
- Target Price
- OBK $36.80
- SEPN $43.67
- AVG Volume (30 Days)
- OBK 142.1K
- SEPN 418.6K
- Earning Date
- OBK 01-22-2025
- SEPN 02-15-2025
- Dividend Yield
- OBK 1.71%
- SEPN N/A
- EPS Growth
- OBK N/A
- SEPN N/A
- EPS
- OBK 2.43
- SEPN N/A
- Revenue
- OBK $343,330,000.00
- SEPN $981,000.00
- Revenue This Year
- OBK N/A
- SEPN $406.62
- Revenue Next Year
- OBK $3.11
- SEPN N/A
- P/E Ratio
- OBK $14.45
- SEPN N/A
- Revenue Growth
- OBK N/A
- SEPN N/A
- 52 Week Low
- OBK $27.69
- SEPN $15.86
- 52 Week High
- OBK $37.56
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- OBK 62.40
- SEPN N/A
- Support Level
- OBK $34.27
- SEPN N/A
- Resistance Level
- OBK $36.43
- SEPN N/A
- Average True Range (ATR)
- OBK 0.94
- SEPN 0.00
- MACD
- OBK 0.30
- SEPN 0.00
- Stochastic Oscillator
- OBK 84.14
- SEPN 0.00
About OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.